Home About ISR Investor Relations Media Room

News 2017-05-21

ISR clarifies the company's strategies for clinical trials in HIV

Files & documents

ISR Strategies for clinical trials in Swedish (PDF)

Previous Next

Twitter ISR on Nasdaq

© ISR Immune System Regulation Holding AB (publ). All rights reserved.

Retzius väg 11

SE-171 65 Solna, Sweden

Email: info@israb.se

Phone: +46 705 42 79 39